Search results

Filter (6 in use)

Area of interest 1 selected

  • Remove filter for COVID-19 (2)

Type 1 selected

  • Remove filter for Guidance (2)

Status 2 selected

  • Remove filter for In development (2)
  • Filter by Topic selection (1)
  • Remove filter for Proposed (0)

Last updated

  • Filter by Last 3 months (0)
  • Filter by Last 6 months (0)
  • Filter by Last year (0)
  • Filter by Last 3 years (0)

Guidance programme 2 selected

  • Filter by Interventional procedures guidance (2)
  • Filter by NICE guidelines (2)
  • Remove filter for Technology appraisal guidance (2)
  • Filter by Clinical guidelines (1)
  • Filter by Diagnostics guidance (1)
  • Remove filter for Social care guidelines (0)

2 results

Sorted by Relevance . | Sort by Date

  • COVID-19 Remove COVID-19 filter
  • Guidance Remove Guidance filter
  • In development Remove In development filter
  • Proposed Remove Proposed filter
  • Technology appraisal guidance Remove Technology appraisal guidance filter
  • Social care guidelines Remove Social care guidelines filter
  1. Tixagevimab–cilgavimab for preventing COVID-19 [ID6136]

    In development [GID-TA11102] Expected publication date: TBC

    Type
    Technology appraisal guidance
    Status
    In development
  2. Therapeutics for people with COVID-19 [ID4038]

    In development [GID-TA10936] Expected publication date: TBC

    Type
    Technology appraisal guidance
    Status
    In development